These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9695196)

  • 1. Prospective individual matching: covariate balance and power in a comparative study.
    Makuch RW; Zhang Z; Charpentier PA; Inouye SK
    Stat Med; 1998 Jul; 17(13):1517-26. PubMed ID: 9695196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal multivariate matching before randomization.
    Greevy R; Lu B; Silber JH; Rosenbaum P
    Biostatistics; 2004 Apr; 5(2):263-75. PubMed ID: 15054030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomization, matching, and propensity scores in the design and analysis of experimental studies with measured baseline covariates.
    Loux TM
    Stat Med; 2015 Feb; 34(4):558-70. PubMed ID: 25384851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covariate-based constrained randomization of group-randomized trials.
    Moulton LH
    Clin Trials; 2004; 1(3):297-305. PubMed ID: 16279255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocked randomization with randomly selected block sizes.
    Efird J
    Int J Environ Res Public Health; 2011 Jan; 8(1):15-20. PubMed ID: 21318011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pursuit of balance: An overview of covariate-adaptive randomization techniques in clinical trials.
    Lin Y; Zhu M; Su Z
    Contemp Clin Trials; 2015 Nov; 45(Pt A):21-5. PubMed ID: 26244705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials.
    Berger VW
    Biom J; 2005 Apr; 47(2):119-27; discussion 128-39. PubMed ID: 16389910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple, flexible, and effective covariate-adaptive treatment allocation procedure.
    Loux TM
    Stat Med; 2013 Sep; 32(22):3775-87. PubMed ID: 23637002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New designs for the selection of treatments to be tested in randomized clinical trials.
    Simon R; Thall PF; Ellenberg SS
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):417-29. PubMed ID: 8023026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seamless Phase II/III combination study through response adaptive randomization.
    Wang L; Cui L
    J Biopharm Stat; 2007; 17(6):1177-87. PubMed ID: 18027224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Propensity score methods for creating covariate balance in observational studies].
    Pattanayak CW; Rubin DB; Zell ER
    Rev Esp Cardiol; 2011 Oct; 64(10):897-903. PubMed ID: 21872981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical aspects of controlled single subject trials.
    Johannessen T; Fosstvedt D; Petersen H
    Fam Pract; 1990 Dec; 7(4):325-8. PubMed ID: 2289647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reweighted Mahalanobis distance matching for cluster-randomized trials with missing data.
    Greevy RA; Grijalva CG; Roumie CL; Beck C; Hung AM; Murff HJ; Liu X; Griffin MR
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2(0 2):148-54. PubMed ID: 22552990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Add-Arm Design for Unimodal Response Curve with Unknown Mode.
    Chang M; Wang J
    J Biopharm Stat; 2015; 25(5):1039-64. PubMed ID: 25331003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust extraction of covariate information to improve estimation efficiency in randomized trials.
    Moore KL; Neugebauer R; Valappil T; Laan MJ
    Stat Med; 2011 Aug; 30(19):2389-408. PubMed ID: 21751231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing predictability while retaining balance through the use of less restrictive randomization procedures.
    Berger VW; Ivanova A; Knoll MD
    Stat Med; 2003 Oct; 22(19):3017-28. PubMed ID: 12973784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False positive rates of randomized phase II designs.
    Liu PY; LeBlanc M; Desai M
    Control Clin Trials; 1999 Aug; 20(4):343-52. PubMed ID: 10440561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimization in randomized clinical trials.
    Coart E; Bamps P; Quinaux E; Sturbois G; Saad ED; Burzykowski T; Buyse M
    Stat Med; 2023 Dec; 42(28):5285-5311. PubMed ID: 37867447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of randomization on the analysis of clinical trials.
    Rosenkranz GK
    Stat Med; 2011 Dec; 30(30):3475-87. PubMed ID: 21953285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.